American Heart Association
Exploring the CV Effects and Real-World Usage of GLP1 Receptor Agonists and SGLT2i
Abstract Poster Session
Zone 3
Nov 17th , 11:30 AM - 12:30 PM
11 : 30 AM
Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
Nakhla Michael, Dani Sourbha, V Ambica, Balani Prachi, Ujjawal Aditi, Arun Kumar Pramukh, Dasari Mahati, Yukselen Zeynep, Bansal Kannu, Ganatra Sarju
Final Pr. ID: Su3013
Authors: Nakhla Michael, Dani Sourbha, V Ambica, Balani Prachi, Ujjawal Aditi, Arun Kumar Pramukh, Dasari Mahati, Yukselen Zeynep, Bansal Kannu, Ganatra Sarju
Keywords: Diabetes Mellitus , Pharmacology , Heart failure , Prevention
11 : 30 AM
Eligibility for Semaglutide in US Adults with Diabetes and Potentially Preventable Cardiovascular Events Projected from the SUSTAIN-6 Trial
Wong Nathan, Karthikeyan Hridhay, Fan Wenjun
Final Pr. ID: Su3016
Authors: Wong Nathan, Karthikeyan Hridhay, Fan Wenjun
Keywords: Diabetes (Type II) , Cardiovascular disease prevention , Epidemiology , Risk Factors
11 : 30 AM
Effects Of Semaglutide On Safety Outcomes In Patients With Type 2 Diabetes Mellitus And High Cardiovascular Risk: A Meta-Analysis Of Randomized Controlled Trials And Systematic Review
Cruz Akabane Maria Antonia, Mazetto Roberto, Ribeiro Iury, Cavalcante Douglas, Barbosa Imara
Final Pr. ID: Su3017
Authors: Cruz Akabane Maria Antonia, Mazetto Roberto, Ribeiro Iury, Cavalcante Douglas, Barbosa Imara
Keywords: Diabetes (Type II) , Cardiovascular disease , Kidney Disease
11 : 30 AM
Racial Differences in Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among US Veterans with Type 2 Diabetes and Coronary Artery Disease
Bolden Demetria
Final Pr. ID: Su3012
Authors: Bolden Demetria
Keywords: Cardiovascular disease , Diabetes (Type II)
Rivera Frederick, Mahilum Mer Lorraine, Mangubat Gerard Francis, Magalong John, Ansay Marie Francesca, Zelenkov Nenad, Vijayaraghavan Krishnaswami, Ruyeras Jade Monica Marie, Amigo John Andrew, Ong Kenneth
Final Pr. ID: Su3010
Authors: Rivera Frederick, Mahilum Mer Lorraine, Mangubat Gerard Francis, Magalong John, Ansay Marie Francesca, Zelenkov Nenad, Vijayaraghavan Krishnaswami, Ruyeras Jade Monica Marie, Amigo John Andrew, Ong Kenneth
Keywords: Diabetes (Type II) , Cardiovascular disease , Drugs , Obesity , Safety
11 : 30 AM
Uncovering the Gaps: Analyzing Prescribing Patterns of Combination Therapy with SGLT2-inhibitors and GLP-1 Receptor Agonists in Established Atherosclerotic Cardiovascular Disease (ASCVD) and Type 2 Diabetes (T2DM)
Khetrapal Sanchaya, Gadani Mrudula, Manalo Kathryn, Oehler Andrew, Yin Yue, Pratapneni Siddarth, Pulipati Yochitha, Shah Aaisha
Final Pr. ID: Su3015
Authors: Khetrapal Sanchaya, Gadani Mrudula, Manalo Kathryn, Oehler Andrew, Yin Yue, Pratapneni Siddarth, Pulipati Yochitha, Shah Aaisha
Keywords: SDOH , Guidelines , Diabetes (Type II) , Cardiovascular disease prevention
11 : 30 AM
Effect of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, on Systolic Blood Pressure in Patients with Type 2 Diabetes
Hardin Marquette, Davies Michael, Carroll Amy, Umpierrez Guillermo
Final Pr. ID: Su3019
Authors: Hardin Marquette, Davies Michael, Carroll Amy, Umpierrez Guillermo
Keywords: Blood pressure , Diabetes (Type II)
11 : 30 AM
Comparative cardiovascular efficacy of empagliflozin and dapagliflozin in patients with type 2 diabetes: A systematic review and meta-analysis
Samad Muhammad Ammar, Ahmed Raheel, Mahboob Eman, Ahmed Mushood, Farooqui Sabeeh, Tahir Ali Shaikh, Akhtar Shanzay, Ahmad Adeel, Rahman Asad, Jain Hritvik
Final Pr. ID: Su3014
Authors: Samad Muhammad Ammar, Ahmed Raheel, Mahboob Eman, Ahmed Mushood, Farooqui Sabeeh, Tahir Ali Shaikh, Akhtar Shanzay, Ahmad Adeel, Rahman Asad, Jain Hritvik
Keywords: Diabetes (Type II)
11 : 30 AM
Individual- and Community-level Socioeconomic Differences in Use of GLP-1 Receptor Agonists in Diabetes
Chaudhary Richard, Decker Sergio, Song Yang, Khan Sadiya, Ndumele Chiadi, Kazi Dhruv
Final Pr. ID: Su3018
Authors: Chaudhary Richard, Decker Sergio, Song Yang, Khan Sadiya, Ndumele Chiadi, Kazi Dhruv
Keywords: Cardiometabolic health
11 : 30 AM
Association of Lipoprotein(a) with Cardiovascular Outcomes Across the Spectrum of HbA1c Levels
Alebna Pamela, Shapiro Michael, Bhatia Harpreet, Mehta Anurag, Ambrosio Mathew, Akakpo Divine, Bolden Gabrielle, Razavi Alexander, Chew Nicholas, Hundley William, Salloum Fadi, Sperling Laurence
Final Pr. ID: Su3011
Authors: Alebna Pamela, Shapiro Michael, Bhatia Harpreet, Mehta Anurag, Ambrosio Mathew, Akakpo Divine, Bolden Gabrielle, Razavi Alexander, Chew Nicholas, Hundley William, Salloum Fadi, Sperling Laurence
Keywords: Lipoproteins , Diabetes (Type I)
11 : 30 AM
Association of Lipoprotein(a) with Cardiovascular Outcomes Across the Spectrum of HbA1c Levels
Alebna Pamela, Shapiro Michael, Bhatia Harpreet, Mehta Anurag, Ambrosio Mathew, Akakpo Divine, Bolden Gabrielle, Razavi Alexander, Chew Nicholas, Hundley William, Salloum Fadi, Sperling Laurence
Final Pr. ID: Su3011
Authors: Alebna Pamela, Shapiro Michael, Bhatia Harpreet, Mehta Anurag, Ambrosio Mathew, Akakpo Divine, Bolden Gabrielle, Razavi Alexander, Chew Nicholas, Hundley William, Salloum Fadi, Sperling Laurence
Keywords: Lipoproteins , Diabetes (Type I)
11 : 30 AM
Comparative cardiovascular efficacy of empagliflozin and dapagliflozin in patients with type 2 diabetes: A systematic review and meta-analysis
Samad Muhammad Ammar, Ahmed Raheel, Mahboob Eman, Ahmed Mushood, Farooqui Sabeeh, Tahir Ali Shaikh, Akhtar Shanzay, Ahmad Adeel, Rahman Asad, Jain Hritvik
Final Pr. ID: Su3014
Authors: Samad Muhammad Ammar, Ahmed Raheel, Mahboob Eman, Ahmed Mushood, Farooqui Sabeeh, Tahir Ali Shaikh, Akhtar Shanzay, Ahmad Adeel, Rahman Asad, Jain Hritvik
Keywords: Diabetes (Type II)
11 : 30 AM
Effect of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, on Systolic Blood Pressure in Patients with Type 2 Diabetes
Hardin Marquette, Davies Michael, Carroll Amy, Umpierrez Guillermo
Final Pr. ID: Su3019
Authors: Hardin Marquette, Davies Michael, Carroll Amy, Umpierrez Guillermo
Keywords: Blood pressure , Diabetes (Type II)
11 : 30 AM
Effects Of Semaglutide On Safety Outcomes In Patients With Type 2 Diabetes Mellitus And High Cardiovascular Risk: A Meta-Analysis Of Randomized Controlled Trials And Systematic Review
Cruz Akabane Maria Antonia, Mazetto Roberto, Ribeiro Iury, Cavalcante Douglas, Barbosa Imara
Final Pr. ID: Su3017
Authors: Cruz Akabane Maria Antonia, Mazetto Roberto, Ribeiro Iury, Cavalcante Douglas, Barbosa Imara
Keywords: Diabetes (Type II) , Cardiovascular disease , Kidney Disease
11 : 30 AM
Eligibility for Semaglutide in US Adults with Diabetes and Potentially Preventable Cardiovascular Events Projected from the SUSTAIN-6 Trial
Wong Nathan, Karthikeyan Hridhay, Fan Wenjun
Final Pr. ID: Su3016
Authors: Wong Nathan, Karthikeyan Hridhay, Fan Wenjun
Keywords: Diabetes (Type II) , Cardiovascular disease prevention , Epidemiology , Risk Factors
11 : 30 AM
Individual- and Community-level Socioeconomic Differences in Use of GLP-1 Receptor Agonists in Diabetes
Chaudhary Richard, Decker Sergio, Song Yang, Khan Sadiya, Ndumele Chiadi, Kazi Dhruv
Final Pr. ID: Su3018
Authors: Chaudhary Richard, Decker Sergio, Song Yang, Khan Sadiya, Ndumele Chiadi, Kazi Dhruv
Keywords: Cardiometabolic health
11 : 30 AM
Racial Differences in Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among US Veterans with Type 2 Diabetes and Coronary Artery Disease
Bolden Demetria
Final Pr. ID: Su3012
Authors: Bolden Demetria
Keywords: Cardiovascular disease , Diabetes (Type II)
Rivera Frederick, Mahilum Mer Lorraine, Mangubat Gerard Francis, Magalong John, Ansay Marie Francesca, Zelenkov Nenad, Vijayaraghavan Krishnaswami, Ruyeras Jade Monica Marie, Amigo John Andrew, Ong Kenneth
Final Pr. ID: Su3010
Authors: Rivera Frederick, Mahilum Mer Lorraine, Mangubat Gerard Francis, Magalong John, Ansay Marie Francesca, Zelenkov Nenad, Vijayaraghavan Krishnaswami, Ruyeras Jade Monica Marie, Amigo John Andrew, Ong Kenneth
Keywords: Diabetes (Type II) , Cardiovascular disease , Drugs , Obesity , Safety
11 : 30 AM
Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
Nakhla Michael, Dani Sourbha, V Ambica, Balani Prachi, Ujjawal Aditi, Arun Kumar Pramukh, Dasari Mahati, Yukselen Zeynep, Bansal Kannu, Ganatra Sarju
Final Pr. ID: Su3013
Authors: Nakhla Michael, Dani Sourbha, V Ambica, Balani Prachi, Ujjawal Aditi, Arun Kumar Pramukh, Dasari Mahati, Yukselen Zeynep, Bansal Kannu, Ganatra Sarju
Keywords: Diabetes Mellitus , Pharmacology , Heart failure , Prevention
11 : 30 AM
Uncovering the Gaps: Analyzing Prescribing Patterns of Combination Therapy with SGLT2-inhibitors and GLP-1 Receptor Agonists in Established Atherosclerotic Cardiovascular Disease (ASCVD) and Type 2 Diabetes (T2DM)
Khetrapal Sanchaya, Gadani Mrudula, Manalo Kathryn, Oehler Andrew, Yin Yue, Pratapneni Siddarth, Pulipati Yochitha, Shah Aaisha
Final Pr. ID: Su3015
Authors: Khetrapal Sanchaya, Gadani Mrudula, Manalo Kathryn, Oehler Andrew, Yin Yue, Pratapneni Siddarth, Pulipati Yochitha, Shah Aaisha
Keywords: SDOH , Guidelines , Diabetes (Type II) , Cardiovascular disease prevention